Company · CIK 1751912
NERVGEN PHARMA CORP.
| CIK | 1751912 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Listed | NGEN (Nasdaq) |
| First annual or quarterly report | 2026-03-31 |
Offerings
0 registrationsNo offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.
Filings
2| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-26 | EFFECTDeclared effective | 333-296217 | 9999999995-26-001763 |
| 2026-01-07 | EFFECTDeclared effective | 333-292197 | 9999999995-26-000094 |